相关实验视频

Updated: Sep 14, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

基于孟德尔的随机化研究和生物信息学方法,探索血清尿酸和胃肠癌之间的因果关系

Kaichen Han¹, Huaizhu Chu², Yongwen Li¹

¹Qinghai University, Xining, China.

|July 23, 2025

概括

血清尿酸 (SUA) 可能降低胃癌 (GC) 的风险,但没有显示与结直肠癌 (CRC) 的因果关系. 生物信息学分析表明,代谢途径可能解释了SUA-GC连接.

科学领域:

遗传学和流行病学
代谢性疾病研究研究

背景情况:

观察性研究表明,血清尿酸 (SUA) 与胃癌 (GC) 和结肠直肠癌 (CRC) 之间存在联系.
潜在的生物学机制和因果关系仍然不清楚.

研究的目的:

调查血清尿酸 (SUA) 水平与发展GC和CRC的风险之间的潜在因果关系.
探索生物途径,可能调解SUA和这些癌症之间的关联.

主要方法:

利用两个样本的门德尔随机化 (MR) 分析与全基因组关联研究的总结数据.
采用反变量加权 (IVW) 作为主要方法,支持加权中位数,MR-Egger和其他技术.
进行生物信息学分析以确定潜在的生物途径和枢纽基因.

主要成果:

门德尔随机分析表明,较高的血清尿酸 (SUA) 水平显著降低了胃癌 (GC) 的风险 (OR=0.804,P=0.002).
没有观察到SUA对结直肠癌 (CRC) 风险的显著因果作用 (OR=0.999,P=0.080).
生物信息学确定了10个在代谢途径中丰富的枢纽基因,包括AMPK信号,脂质,葡萄糖和胆固醇代谢.

结论:

血清尿酸 (SUA) 似乎对胃癌 (GC) 有保护作用,独立于结肠直肠癌 (CRC) 风险.
代谢过程,特别是涉及脂质和葡萄糖代谢的代谢过程,可能会调解SUA和GC之间观察到的逆关系.

关键词:

2个样本门德尔随机化门德尔随机化生物信息学是一种生物信息学.结肠直肠癌是什么意思胃癌胃癌是一种胃癌.血清尿酸是血清中的尿酸.

更多相关视频

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...